<Record>
<Term>GM-CSF-Encoding Oncolytic Herpes Simplex Virus</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Oncolytic Virus</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Immunostimulant/GM-CSF-Encoding Oncolytic Herpes Simplex Virus,/NCIThesaurus/Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Agent/Oncolytic Virus/GM-CSF-Encoding Oncolytic Herpes Simplex Virus</ClassificationPath>
<BroaderTerm>GM-CSF-Encoding Oncolytic Herpes Simplex Virus,</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Biological Agent</BroaderTerm>
<BroaderTerm>NCIThesaurus</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Oncolytic Virus</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>GM-CSF-Encoding Oncolytic Herpes Simplex Virus</BroaderTerm>
<BroaderTerm>Immunostimulant</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>GM-CSF-Encoding Oncolytic Herpes Simplex Virus</Synonym>
<Synonym>OncoVEX GM-CSF</Synonym>
<Description>An oncolytic, recombinant herpes simplex type-1 virus (HSV) encoding human cytokine granulocyte-macrophage colony stimulating factor (GM-CSF) with potential immunostimulating and antineoplastic activities. Upon administration, GM-CSF-encoding oncolytic HSV selectively infects and replicates in tumor cells, thereby inducing tumor cell lysis. In addition, expressed GM-CSF may stimulate a cytotoxic T cell response against tumor cells, resulting in immune-mediated tumor cell death in addition to HSV-mediated oncolytic tumor cell death.</Description>
<Source>NCI Thesaurus</Source>
</Record>
